Skip to main content

Table 1 Baseline demographics

From: Short-term aspirin and statin chemoprophylaxis did not reduce the risk of developing advanced adenomatous polyps in Black patients

Advanced adenomatous polyp on subsequent colonoscopy?

Variables

 

No (number/percent)

Yes (number/percent)

p-value

Sex

Female

411 (55.09)

108 (47.79)

0.05

 

Male

335 (44.91)

118 (52.21)

 

Statin use

No

221 (42.02)

41 (33.88)

0.10

 

Yes

305 (57.98)

80 (66.12)

 

Tobacco use

Never

250 (33.88)

58 (25.89)

< 0.001

 

Quit

249 (33.74)

109 (48.66)

 
 

Yes

239 (32.38)

57 (25.45)

 

Aspirin use

No

252 (33.78)

79 (34.96)

0.74

 

Yes

494 (66.22)

147 (65.04)

 

Documented race

Black/African-American

641 (85.92)

185 (81.86)

0.13

 

Non-Black

105 (14.08)

41 (18.14)

 

Statin and aspirin use

Both

236 (51.98)

59 (55.66)

0.56

 

Part/None

218 (48.02)

47 (44.34)

 

Age at first colonoscopy

 

59.04 (8.99)

59.54 (8.05)

0.43

Body mass index

 

30.21 (7.17)

31.26 (7.49)

0.07